Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Harvard Business School
Cerilliant
Colorcon
Julphar
Queensland Health
Mallinckrodt
QuintilesIMS
Chinese Patent Office
AstraZeneca
Citi

Generated: August 17, 2017

DrugPatentWatch Database Preview

DEMI-REGROTON Drug Profile

« Back to Dashboard

What is the patent landscape for Demi-regroton, and what generic Demi-regroton alternatives are available?

Demi-regroton is a drug marketed by Sanofi Aventis Us and is included in one NDA.

The generic ingredient in DEMI-REGROTON is chlorthalidone; reserpine. There are fifteen drug master file entries for this compound. Additional details are available on the chlorthalidone; reserpine profile page.

Summary for Tradename: DEMI-REGROTON

Patents:0
Applicants:1
NDAs:1
Clinical Trials: see list1
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:DEMI-REGROTON at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sanofi Aventis Us
DEMI-REGROTON
chlorthalidone; reserpine
TABLET;ORAL015103-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

UBS
Federal Trade Commission
Chinese Patent Office
Mallinckrodt
Queensland Health
Baxter
US Army
Covington
Healthtrust
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot